TEAM
Jordi Martorell
CEO and Co-Founder
PhD in Chemical Engineering and specialized in Biomedical Engineering. He is the Head of Vascular Engineering and Applied Medicine and assistant professor at IQS School of Engineering. Jordi has been focused on vascular biology for more than ten years at MIT and IQS. He has collaborated with medical device companies to improve the design of coronary stents and arterial valves.
PhD in Chemical Engineering and specialized in Biomedical Engineering. He is the Head of Vascular Engineering and Applied Medicine and assistant professor at IQS School of Engineering. Jordi has been focused on vascular biology for more than ten years at MIT and IQS. He has collaborated with medical device companies to improve the design of coronary stents and arterial valves.
PhD in Chemical Engineering and specialized in Biomedical Engineering. He is the Head of Vascular Engineering and Applied Medicine and assistant professor at IQS School of Engineering. Jordi has been focused on vascular biology for more than ten years at MIT and IQS. He has collaborated with medical device companies to improve the design of coronary stents and arterial valves.
Noemí Balà
CTO and Co-Founder
PhD Candidate in Chemical Engineering. Noemí has been working on this project since 2016, she has designed and executed biomaterial and bioadhesive synthesis, mechanical testing, plasma technology for protein attachment and cell culture techniques for tissue regeneration.
PhD Candidate in Chemical Engineering. Noemí has been working on this project since 2016, she has designed and executed biomaterial and bioadhesive synthesis, mechanical testing, plasma technology for protein attachment and cell culture techniques for tissue regeneration.
PhD Candidate in Chemical Engineering. Noemí has been working on this project since 2016, she has designed and executed biomaterial and bioadhesive synthesis, mechanical testing, plasma technology for protein attachment and cell culture techniques for tissue regeneration.
Salvador Borrós
CSO and Co-Founder
PhD in Analytical Chemistry Materials. He is the Director at IQS and Head of the Materials Engineering Group (GEMAT). Dr. Borrós is Professor of Material Sciences since 1994. His research on industrial polymers pivoted in 2005 to intelligent biomaterials. His portfolio of human applications includes tissue regeneration, nanoparticles or synthetic vectors for drug or gene delivery.
PhD in Analytical Chemistry Materials. He is the Director at IQS and Head of the Materials Engineering Group (GEMAT). Dr. Borrós is Professor of Material Sciences since 1994. His research on industrial polymers pivoted in 2005 to intelligent biomaterials. His portfolio of human applications includes tissue regeneration, nanoparticles or synthetic vectors for drug or gene delivery.
PhD in Analytical Chemistry Materials. He is the Director at IQS and Head of the Materials Engineering Group (GEMAT). Dr. Borrós is Professor of Material Sciences since 1994. His research on industrial polymers pivoted in 2005 to intelligent biomaterials. His portfolio of human applications includes tissue regeneration, nanoparticles or synthetic vectors for drug or gene delivery.
PhD in Analytical Chemistry Materials. He is the Director at IQS and Head of the Materials Engineering Group (GEMAT). Dr. Borrós is Professor of Material Sciences since 1994. His research on industrial polymers pivoted in 2005 to intelligent biomaterials. His portfolio of human applications includes tissue regeneration, nanoparticles or synthetic vectors for drug or gene delivery.
PhD in Analytical Chemistry Materials. He is the Director at IQS and Head of the Materials Engineering Group (GEMAT). Dr. Borrós is Professor of Material Sciences since 1994. His research on industrial polymers pivoted in 2005 to intelligent biomaterials. His portfolio of human applications includes tissue regeneration, nanoparticles or synthetic vectors for drug or gene delivery.
Vicenç Riambau
Medical Liaison and Co-Founder
MD and PhD in Medicine. Vicenç is the Chief of Vascular Surgery at Hospital Clínic de Barcelona. Dr. Riambau is a specialist and worldwide key opinion leader in Endovascular Surgery. He has been President or Vice-President of the most important international societies for Vascular Surgery. He is devoted to delivering the best available treatment to our patients by strongly collaborating with the medical device industry. He has been involved in dozens of clinical trials for novel vascular treatments, and consults for almost every vascular device company.
MD and PhD in Medicine. Vicenç is the Chief of Vascular Surgery at Hospital Clínic de Barcelona. Dr. Riambau is a specialist and worldwide key opinion leader in Endovascular Surgery. He has been President or Vice-President of the most important international societies for Vascular Surgery. He is devoted to delivering the best available treatment to our patients by strongly collaborating with the medical device industry. He has been involved in dozens of clinical trials for novel vascular treatments, and consults for almost every vascular device company.
MD and PhD in Medicine. Vicenç is the Chief of Vascular Surgery at Hospital Clínic de Barcelona. Dr. Riambau is a specialist and worldwide key opinion leader in Endovascular Surgery. He has been President or Vice-President of the most important international societies for Vascular Surgery. He is devoted to delivering the best available treatment to our patients by strongly collaborating with the medical device industry. He has been involved in dozens of clinical trials for novel vascular treatments, and consults for almost every vascular device company.
Alex Aranda
R&D
R&D
R&D
PhD Candidate in Bioengineering. Alex has been developing and validating the patch intravascular deployer and the deployment system of the patch, coupling his ideas and knowledge in materials, design and manufacturing with the insights from clinical surgeons and university professors.
PhD Candidate in Bioengineering. Alex has been developing and validating the patch intravascular deployer and the deployment system of the patch, coupling his ideas and knowledge in materials, design and manufacturing with the insights from clinical surgeons and university professors.
PhD Candidate in Bioengineering. Alex has been developing and validating the patch intravascular deployer and the deployment system of the patch, coupling his ideas and knowledge in materials, design and manufacturing with the insights from clinical surgeons and university professors.
PhD Candidate in Bioengineering. Alex has been developing and validating the patch intravascular deployer and the deployment system of the patch, coupling his ideas and knowledge in materials, design and manufacturing with the insights from clinical surgeons and university professors.
Pau Teixidó
R&D
R&D
R&D
PhD Candidate in Chemistry and Chemical Engineering. Pau has been working on this project since 2018, he has designed and executed ex-vivo tests, degradation and cytotoxicity assays and surface modification for the adhesives.
PhD Candidate in Chemistry and Chemical Engineering. Pau has been working on this project since 2018, he has designed and executed ex-vivo tests, degradation and cytotoxicity assays and surface modification for the adhesives.
PhD Candidate in Chemistry and Chemical Engineering. Pau has been working on this project since 2018, he has designed and executed ex-vivo tests, degradation and cytotoxicity assays and surface modification for the adhesives.
PhD Candidate in Chemistry and Chemical Engineering. Pau has been working on this project since 2018, he has designed and executed ex-vivo tests, degradation and cytotoxicity assays and surface modification for the adhesives.
PhD Candidate in Chemistry and Chemical Engineering. Pau has been working on this project since 2018, he has designed and executed ex-vivo tests, degradation and cytotoxicity assays and surface modification for the adhesives.
Inés Moreno
R&D
R&D
R&D
Research Scientist. Inés completed her PhD in 2016 working in the field of tissue engineering and regenerative medicine. Inés has a broad international experience (University of Southampton, Linköping University, Queensland University of Technology), working in in vitro and in vivo testing of biomaterials in angiogenesis. In Aortyx she focuses on the combination of the bioadhesive patch with peptides and drugs and the pre-clinical validation of these models.
Research Scientist. Inés completed her PhD in 2016 working in the field of tissue engineering and regenerative medicine. Inés has a broad international experience (University of Southampton, Linköping University, Queensland University of Technology), working in in vitro and in vivo testing of biomaterials in angiogenesis. In Aortyx she focuses on the combination of the bioadhesive patch with peptides and drugs and the pre-clinical validation of these models.
Research Scientist. Inés completed her PhD in 2016 working in the field of tissue engineering and regenerative medicine. Inés has a broad international experience (University of Southampton, Linköping University, Queensland University of Technology), working in in vitro and in vivo testing of biomaterials in angiogenesis. In Aortyx she focuses on the combination of the bioadhesive patch with peptides and drugs and the pre-clinical validation of these models.
Research Scientist. Inés completed her PhD in 2016 working in the field of tissue engineering and regenerative medicine. Inés has a broad international experience (University of Southampton, Linköping University, Queensland University of Technology), working in in vitro and in vivo testing of biomaterials in angiogenesis. In Aortyx she focuses on the combination of the bioadhesive patch with peptides and drugs and the pre-clinical validation of these models.
Research Scientist. Inés completed her PhD in 2016 working in the field of tissue engineering and regenerative medicine. Inés has a broad international experience (University of Southampton, Linköping University, Queensland University of Technology), working in in vitro and in vivo testing of biomaterials in angiogenesis. In Aortyx she focuses on the combination of the bioadhesive patch with peptides and drugs and the pre-clinical validation of these models.
Carlota Molhoek
R&D
R&D
R&D
Graduate in Industrial Engineering and MSc in Robotics and Automation. She specialised in Bioengineering at Illinois Institute of Technology. Carlota is part of R&D Engineering team and she is focused on the development and validation of the intravascular deployment system of the patch. She has been designing the adhesive delivery system.
Graduate in Industrial Engineering and MSc in Robotics and Automation. She specialised in Bioengineering at Illinois Institute of Technology. Carlota is part of R&D Engineering team and she is focused on the development and validation of the intravascular deployment system of the patch. She has been designing the adhesive delivery system.
Graduate in Industrial Engineering and MSc in Robotics and Automation. She specialised in Bioengineering at Illinois Institute of Technology. Carlota is part of R&D Engineering team and she is focused on the development and validation of the intravascular deployment system of the patch. She has been designing the adhesive delivery system.
Graduate in Industrial Engineering and MSc in Robotics and Automation. She specialised in Bioengineering at Illinois Institute of Technology. Carlota is part of R&D Engineering team and she is focused on the development and validation of the intravascular deployment system of the patch. She has been designing the adhesive delivery system.
Graduate in Industrial Engineering and MSc in Robotics and Automation. She specialised in Bioengineering at Illinois Institute of Technology. Carlota is part of R&D Engineering team and she is focused on the development and validation of the intravascular deployment system of the patch. She has been designing the adhesive delivery system.
Carlos Delso
Regulatory Affairs Director
Regulatory Affairs Director
Regulatory Affairs Director
Pharmacist, MSc in Molecular Biology and MBA. Carlos has extensive experience in Regulatory Affairs in Biological Combination Products and Medical Devices as an independent consultant.
At Aortyx, he focuses on assuring compliance with appropriate standards and regulations for FDA approval and CE mark obtention to help fulfilling the company’s vision.
Pharmacist, MSc in Molecular Biology and MBA. Carlos has extensive experience in Regulatory Affairs in Biological Combination Products and Medical Devices as an independent consultant.
At Aortyx, he focuses on assuring compliance with appropriate standards and regulations for FDA approval and CE mark obtention to help fulfilling the company’s vision.
Pharmacist, MSc in Molecular Biology and MBA. Carlos has extensive experience in Regulatory Affairs in Biological Combination Products and Medical Devices as an independent consultant.
At Aortyx, he focuses on assuring compliance with appropriate standards and regulations for FDA approval and CE mark obtention to help fulfilling the company’s vision.
Pharmacist, MSc in Molecular Biology and MBA. Carlos has extensive experience in Regulatory Affairs in Biological Combination Products and Medical Devices as an independent consultant.
At Aortyx, he focuses on assuring compliance with appropriate standards and regulations for FDA approval and CE mark obtention to help fulfilling the company’s vision.
Pharmacist, MSc in Molecular Biology and MBA. Carlos has extensive experience in Regulatory Affairs in Biological Combination Products and Medical Devices as an independent consultant.
At Aortyx, he focuses on assuring compliance with appropriate standards and regulations for FDA approval and CE mark obtention to help fulfilling the company’s vision.
Germán Febas
R&D
R&D
R&D
Germán is a Biologist focused on applied science in biomedicine. He has experience in the development of a medical device used in fetal surgery. He masters a number of manufacturing techniques involving biological tissue, biomaterials, bioadhesives, polymeric coatings and electrospinning.
Germán is a Biologist focused on applied science in biomedicine. He has experience in the development of a medical device used in fetal surgery. He masters a number of manufacturing techniques involving biological tissue, biomaterials, bioadhesives, polymeric coatings and electrospinning.
Germán is a Biologist focused on applied science in biomedicine. He has experience in the development of a medical device used in fetal surgery. He masters a number of manufacturing techniques involving biological tissue, biomaterials, bioadhesives, polymeric coatings and electrospinning.
Germán is a Biologist focused on applied science in biomedicine. He has experience in the development of a medical device used in fetal surgery. He masters a number of manufacturing techniques involving biological tissue, biomaterials, bioadhesives, polymeric coatings and electrospinning.
Germán is a Biologist focused on applied science in biomedicine. He has experience in the development of a medical device used in fetal surgery. He masters a number of manufacturing techniques involving biological tissue, biomaterials, bioadhesives, polymeric coatings and electrospinning.
Juan Fusté
Project Manager
Graduate in Biotechnology and MSc in Pharmaceutical design and engineering. Juan has previous experience in the field of cardiac and vascular regenerative medicine, at the Technical University of Denmark as well as at IQS School of Engineering. He is in charge of optimising grants management, communications and Aortyx’ roadmap accomplishment.
Graduate in Biotechnology and MSc in Pharmaceutical design and engineering. Juan has previous experience in the field of cardiac and vascular regenerative medicine, at the Technical University of Denmark as well as at IQS School of Engineering. He is in charge of optimising grants management, communications and Aortyx’ roadmap accomplishment.
Graduate in Biotechnology and MSc in Pharmaceutical design and engineering. Juan has previous experience in the field of cardiac and vascular regenerative medicine, at the Technical University of Denmark as well as at IQS School of Engineering. He is in charge of optimising grants management, communications and Aortyx’ roadmap accomplishment.
Graduate in Biotechnology and MSc in Pharmaceutical design and engineering. Juan has previous experience in the field of cardiac and vascular regenerative medicine, at the Technical University of Denmark as well as at IQS School of Engineering. He is in charge of optimising grants management, communications and Aortyx’ roadmap accomplishment.
Graduate in Biotechnology and MSc in Pharmaceutical design and engineering. Juan has previous experience in the field of cardiac and vascular regenerative medicine, at the Technical University of Denmark as well as at IQS School of Engineering. He is in charge of optimising grants management, communications and Aortyx’ roadmap accomplishment.
Maite Molins
R&D
R&D
R&D
MSc intern in Industrial Engineering with background in Chemical Engineering. She has previous experience in the field of vascular engineering and regenerative medicine, at the University of Sheffield as well as at IQS School of Engineering. Maite is supporting R&D Engineering and has been working on the optimisation of ex vivo model.
MSc intern in Industrial Engineering with background in Chemical Engineering. She has previous experience in the field of vascular engineering and regenerative medicine, at the University of Sheffield as well as at IQS School of Engineering. Maite is supporting R&D Engineering and has been working on the optimisation of ex vivo model.
MSc intern in Industrial Engineering with background in Chemical Engineering. She has previous experience in the field of vascular engineering and regenerative medicine, at the University of Sheffield as well as at IQS School of Engineering. Maite is supporting R&D Engineering and has been working on the optimisation of ex vivo model.
MSc intern in Industrial Engineering with background in Chemical Engineering. She has previous experience in the field of vascular engineering and regenerative medicine, at the University of Sheffield as well as at IQS School of Engineering. Maite is supporting R&D Engineering and has been working on the optimisation of ex vivo model.
MSc intern in Industrial Engineering with background in Chemical Engineering. She has previous experience in the field of vascular engineering and regenerative medicine, at the University of Sheffield as well as at IQS School of Engineering. Maite is supporting R&D Engineering and has been working on the optimisation of ex vivo model.
Advisory Board
Elazer Edelman
Medical Advisor
MD and Phd. Elazer is the Director of the Institute for Medical Engineering and Science at MIT. He is Thomas D. and Virginia W. Cabot Professor at MIT and Professor of Medicine at Harvard Medical School. Dr. Edelman is also a senior physician in the Cardiac Care Unit at the Brigham and Women’s Hospital. He has more than thirty years of experience in vascular biology and devices invention and he is also a consultant for FDA and several medical devices.
MD and Phd. Elazer is the Director of the Institute for Medical Engineering and Science at MIT. He is Thomas D. and Virginia W. Cabot Professor at MIT and Professor of Medicine at Harvard Medical School. Dr. Edelman is also a senior physician in the Cardiac Care Unit at the Brigham and Women’s Hospital. He has more than thirty years of experience in vascular biology and devices invention and he is also a consultant for FDA and several medical devices.
MD and Phd. Elazer is the Director of the Institute for Medical Engineering and Science at MIT. He is Thomas D. and Virginia W. Cabot Professor at MIT and Professor of Medicine at Harvard Medical School. Dr. Edelman is also a senior physician in the Cardiac Care Unit at the Brigham and Women’s Hospital. He has more than thirty years of experience in vascular biology and devices invention and he is also a consultant for FDA and several medical devices.
Rosendo Garganta
Business Advisor
MBA. Rosendo is the CEO of Devicare, a technology-based company dedicated to develop digital therapeutics solutions. He is also a Clinical and Biomedical Entrepreneur and he collaborates with different Barcelona based Universities as a Visiting Associate Professor in Entrepreneurship.
MBA. Rosendo is the CEO of Devicare, a technology-based company dedicated to develop digital therapeutics solutions. He is also a Clinical and Biomedical Entrepreneur and he collaborates with different Barcelona based Universities as a Visiting Associate Professor in Entrepreneurship.
MBA. Rosendo is the CEO of Devicare, a technology-based company dedicated to develop digital therapeutics solutions. He is also a Clinical and Biomedical Entrepreneur and he collaborates with different Barcelona based Universities as a Visiting Associate Professor in Entrepreneurship.
MBA. Rosendo is the CEO of Devicare, a technology-based company dedicated to develop digital therapeutics solutions. He is also a Clinical and Biomedical Entrepreneur and he collaborates with different Barcelona based Universities as a Visiting Associate Professor in Entrepreneurship.
Mercedes Balcells
Scientific Advisor
PhD in Macromolecular Chemistry. She is a Principal Research Scientist at IMES (MIT) and a full professor at IQS. She has more than fifteen years of experience in vascular biology and biomaterials. In 2010 she founded Regenear, a company focused on developing biokits to regenerate tridimensional facial cartilage from patient’s own cells.
PhD in Macromolecular Chemistry. She is a Principal Research Scientist at IMES (MIT) and a full professor at IQS. She has more than fifteen years of experience in vascular biology and biomaterials. In 2010 she founded Regenear, a company focused on developing biokits to regenerate tridimensional facial cartilage from patient’s own cells.
PhD in Macromolecular Chemistry. She is a Principal Research Scientist at IMES (MIT) and a full professor at IQS. She has more than fifteen years of experience in vascular biology and biomaterials. In 2010 she founded Regenear, a company focused on developing biokits to regenerate tridimensional facial cartilage from patient’s own cells.
Adam Groothuis
Business Advisor
MBA. Adam is the founder of two technological startups and the Vice-President of Mitralign. He has more than twenty years of experience optimizing medical devices for cardiovascular diseases. He is also advisor for several medical devices companies.
MBA. Adam is the founder of two technological startups and the Vice-President of Mitralign. He has more than twenty years of experience optimizing medical devices for cardiovascular diseases. He is also advisor for several medical devices companies.
MBA. Adam is the founder of two technological startups and the Vice-President of Mitralign. He has more than twenty years of experience optimizing medical devices for cardiovascular diseases. He is also advisor for several medical devices companies.
The ultimate solution for aortic diseases
The ultimate solution for aortic diseases
The ultimate solution for aortic diseases
© 2019. AORTYX.